Open AccessAll anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
Author(s) -
Bruce Cree
Publication year - 2022
Publication title -
multiple sclerosis journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/13524585221108294
Subject(s) - monoclonal antibody , multiple sclerosis , medicine , cd20 , antibody , monoclonal , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom